[ Price : $8.95]
CDRH asks for public comment on eight questions about using medical technologies in a home setting.[ Price : $8.95]
A New Jersey oncologist becomes the third doctor to plead guilty to participating in a scheme to purchase prescription oncology dr...[ Price : $8.95]
FDA clears an Ezra 510(k) for its artificial intelligence-enabled Ezra Flash and its use in enhancing MR image quality.[ Price : $8.95]
CDER Office of New Drug Policy director Maarika Kimbrell leaves the agency to re-enter private legal practice at Morgan Lewis as a...[ Price : $8.95]
CDRH announces a 9/6 Patient Engagement Advisory Committee meeting to discuss and make recommendations on Advancing Health Equity ...[ Price : $8.95]
Sanofi says data from a Phase 2 trial of frexalimab significantly reduced disease activity in patients with relapsing multiple scl...[ Price : $8.95]
FDA alerts patients and healthcare providers to concerns about compounded semaglutide that is being produced as an alternative to ...[ Price : $8.95]
The CDER Office of Surveillance and Epidemiology 2022 annual report highlights activities in public health emergencies, drug risk ...